Lanxess (LXS) Given a €78.00 Price Target by UBS Group Analysts
UBS Group set a €78.00 ($90.70) price objective on Lanxess (ETR:LXS) in a research note released on Monday morning, www.boersen-zeitung.de reports. The firm currently has a buy rating on the stock.
Several other research analysts also recently weighed in on LXS. Jefferies Financial Group set a €69.00 ($80.23) target price on Lanxess and gave the stock a neutral rating in a research note on Thursday, August 2nd. Nord/LB set a €74.00 ($86.05) target price on Lanxess and gave the stock a neutral rating in a research note on Wednesday, August 8th. Baader Bank set a €65.00 ($75.58) target price on Lanxess and gave the stock a sell rating in a research note on Thursday, August 2nd. Deutsche Bank set a €68.00 ($79.07) target price on Lanxess and gave the stock a neutral rating in a research note on Friday, September 21st. Finally, Berenberg Bank set a €57.50 ($66.86) target price on Lanxess and gave the stock a sell rating in a research note on Friday, September 14th. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of Hold and an average price target of €73.44 ($85.39).
Shares of ETR:LXS opened at €63.92 ($74.33) on Monday. Lanxess has a 12-month low of €59.89 ($69.64) and a 12-month high of €74.50 ($86.63).
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
See Also: Why does a company issue an IPO?
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.